Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Do Glutamatergic Agents Represent a New Class of Antidepressant Drugs? Part 1 PDF $40.00
$40.00
× Placeholder Sequencing Stimulant Medication and Behavioral Parent Training in Multiplex ADHD Families: A Pilot SMART PDF $40.00
$40.00
× Placeholder Imipramine-Induced Cutaneous and Iris Hyperpigmentation: A Case Report and Literature Review PDF $40.00
$40.00
× Placeholder Lithium Augmentation Fails to Reduce Symptoms in Poorly Responsive Schizophrenic Outpatients PDF $40.00
$40.00
× Placeholder Exploratory Data Mining Analysis Identifying Subgroups of Patients With Depression Who Are at High Risk for Suicide PDF $40.00
$40.00
× Placeholder Ethnicity and Diagnosis in Patients With Affective Disorders PDF $40.00
$40.00
× Placeholder Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes: Results From the Bipolar CHOICE Study PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $280.00
Total $280.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe